{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:41:12Z","timestamp":1782909672936,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004635","name":"Fru Berta Kamprads Stiftelse","doi-asserted-by":"publisher","award":["FBKS-2024-7-583"],"award-info":[{"award-number":["FBKS-2024-7-583"]}],"id":[{"id":"10.13039\/501100004635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["21 1754 Pj 01H"],"award-info":[{"award-number":["21 1754 Pj 01H"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012139","name":"Royal Marsden NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Phys"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The aim was to develop a theoretical framework for how errors in estimated activities propagate to a dispersion in time-integrated activity in radionuclide-therapy dosimetry and how this affects the comparison of radionuclide-therapy dosimetry schemes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Formulae for the variance of relative errors of estimated time-integrated activities and relative differences in time-integrated activities between measurement schemes when one or more time-points are removed were derived using the law of propagation of uncertainty for a population of time-activity-curve parameters. The formulae were derived under the assumptions of fixed coefficients of variation for estimated activities, and underlying mono-exponential curves. Analytical predictions were compared with results from numerical simulations and data for kidneys, liver, and spleen from a data-set of 18 patients treated with <jats:sup>177<\/jats:sup>Lu-DOTA-TATE.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The dispersion in time-integrated activity is minimized if the time-points used for curve fitting have a large dispersion and are centered over the mean of <jats:inline-formula>\n                <jats:alternatives>\n                  <jats:tex-math>$$\\tau ={\\lambda }_{\\text{eff}}^{-1}$$<\/jats:tex-math>\n                  <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                    <mml:mrow>\n                      <mml:mi>\u03c4<\/mml:mi>\n                      <mml:mo>=<\/mml:mo>\n                      <mml:msubsup>\n                        <mml:mi>\u03bb<\/mml:mi>\n                        <mml:mrow>\n                          <mml:mtext>eff<\/mml:mtext>\n                        <\/mml:mrow>\n                        <mml:mrow>\n                          <mml:mo>-<\/mml:mo>\n                          <mml:mn>1<\/mml:mn>\n                        <\/mml:mrow>\n                      <\/mml:msubsup>\n                    <\/mml:mrow>\n                  <\/mml:math>\n                <\/jats:alternatives>\n              <\/jats:inline-formula> over the population, where <jats:inline-formula>\n                <jats:alternatives>\n                  <jats:tex-math>$${\\lambda }_{\\text{eff}}$$<\/jats:tex-math>\n                  <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                    <mml:msub>\n                      <mml:mi>\u03bb<\/mml:mi>\n                      <mml:mtext>eff<\/mml:mtext>\n                    <\/mml:msub>\n                  <\/mml:math>\n                <\/jats:alternatives>\n              <\/jats:inline-formula> is the effective decay constant (<jats:italic>i.e.<\/jats:italic>, the sum of the biological and physical decay constants). For large dispersions of decay constants in the population, the centering of time-points becomes gradually less important. The analytical expressions replicated the main trends from the numerical simulations. Furthermore, the analytical expressions predicted correctly the optimal reduced imaging schedule in 9 of 12 pairwise comparisons between schedules for patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The dispersion of errors and deviations in estimated time-activity curves can be predicted using simple formulae. These formulae have the potential to be used for optimization of dosimetry measurement schemes for established and new radiopharmaceuticals as long as the mean and dispersion of biological half-lives are known in the patient population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40658-025-00721-y","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T03:44:22Z","timestamp":1738813462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["On the reduction of imaging time-points for dosimetry in radionuclide therapy"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1022-8370","authenticated-orcid":false,"given":"Johan","family":"Gustafsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Taprogge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"721_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40644-022-00505-y","volume":"22","author":"JM Beauregard","year":"2022","unstructured":"Beauregard JM. Use of imaging-based dosimetry for personalising radiopharmaceutical therapy of cancer. Cancer Imaging. 2022;22:67.","journal-title":"Cancer Imaging"},{"issue":"41","key":"721_CR2","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1007\/s00259-014-2824-5","volume":"I","author":"L Strigari","year":"2014","unstructured":"Strigari L, Konijnenberg M, Chiesa C, Bardies M, Du Y, Sj\u00f6green Gleisner K, et al. The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy. Eur J Nucl Med Mol. 2014;I(41):1976\u201388.","journal-title":"Eur J Nucl Med Mol"},{"key":"721_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40658-020-0273-8","volume":"7","author":"A Chicheportiche","year":"2020","unstructured":"Chicheportiche A, Ben-Haim S, Grozinsky-Glasberg S, Oleinikov K, Meirovitz A, Gross DJ, et al. Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient management. Ejnmmi Phys. 2020;7:5.","journal-title":"Ejnmmi Phys"},{"key":"721_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40658-018-0224-9","volume":"5","author":"M Del Prete","year":"2018","unstructured":"Del Prete M, Arsenault F, Saighi N, Zhao W, Buteau FA, Celler A, et al. Accuracy and reproducibility of simplified QSPECT dosimetry for personalized 177Lu-octreotate PRRT. Ejnmmi Phys. 2018;5:25.","journal-title":"Ejnmmi Phys"},{"key":"721_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40658-020-00293-z","volume":"7","author":"N Freedman","year":"2020","unstructured":"Freedman N, Sandstr\u00f6m M, Kuten J, Shtraus N, Ospovat I, Schlocker A, et al. Personalized radiation dosimetry for PRRT\u2013how many scans are really required? Ejnmmi Phys. 2020;7:26.","journal-title":"Ejnmmi Phys"},{"key":"721_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40658-020-00339-2","volume":"7","author":"M Sandstr\u00f6m","year":"2020","unstructured":"Sandstr\u00f6m M, Freedman N, Fr\u00f6ss-Baron K, Kahn T, Sundin A. Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points. Ejnmmi Phys. 2020;7:73.","journal-title":"Ejnmmi Phys"},{"key":"721_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40658-018-0210-2","volume":"5","author":"A Sundl\u00f6v","year":"2018","unstructured":"Sundl\u00f6v A, Gustafsson J, Brolin G, Mortensen N, Hermann R, Bernhardt P, et al. Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy. Ejnmmi Phys. 2018;5:12.","journal-title":"Ejnmmi Phys"},{"key":"721_CR8","doi-asserted-by":"publisher","first-page":"175006","DOI":"10.1088\/1361-6560\/ab3039","volume":"64","author":"W Zhao","year":"2019","unstructured":"Zhao W, Esquinas PL, Frezza A, Hou X, Beauregard JM, Celler A. Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a 177Lu-DOTATATE patient study. Phys Med Biol. 2019;64:175006.","journal-title":"Phys Med Biol"},{"key":"721_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13550-023-01007-z","volume":"13","author":"AR Peterson","year":"2023","unstructured":"Peterson AR, Mirando DM, Dewaraja YK. Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in patients and clinically realistic simulations. Ejnmmi Res. 2023;13:57.","journal-title":"Ejnmmi Res"},{"key":"721_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40658-022-00462-2","volume":"9","author":"L Vergnaud","year":"2022","unstructured":"Vergnaud L, Giraudet AL, Moreau A, Salvadori J, Imperiale A, Baudier T, et al. Patient-specific dosimetry adapted to variable number of SPECT\/CT time-points per cycle for 177Lu-DOTATATE therapy. Ejnmmi Phys. 2022;9:37.","journal-title":"Ejnmmi Phys"},{"key":"721_CR11","doi-asserted-by":"publisher","first-page":"103192","DOI":"10.1016\/j.ejmp.2023.103192","volume":"117","author":"OV Ivashchenko","year":"2024","unstructured":"Ivashchenko OV, O\u2019Doherty J, Hardiansyah D, Cremonesi M, Tran-Gia J, Hippelainen E, et al. Time-activity data fitting in molecular radiotherapy: methodology and pitfalls. Phys Med. 2024;117:103192.","journal-title":"Phys Med"},{"key":"721_CR12","doi-asserted-by":"crossref","unstructured":"Huizing DMV, de Wit-van der Veen BJ, Verheij M, Stokkel MPM. Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature review. Ejnmmi Res. 2018;8:89.","DOI":"10.1186\/s13550-018-0443-z"},{"key":"721_CR13","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1002\/mp.14243","volume":"47","author":"P Jackson","year":"2020","unstructured":"Jackson P, McIntosh L, Hofman MS, Kong G, Hicks RJ. Technical Note: Rapid multiexponential curve fitting algorithm for voxel-based targeted radionuclide dosimetry. Med Phys. 2020;47:4332\u20139.","journal-title":"Med Phys"},{"key":"721_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13550-023-00952-z","volume":"13","author":"SMB Peters","year":"2023","unstructured":"Peters SMB, Mink MCT, Prive BM, de Bakker M, de Lange F, Muselaers CHJ, et al. Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation. Ejnmmi Res. 2023;13:6.","journal-title":"Ejnmmi Res"},{"key":"721_CR15","doi-asserted-by":"publisher","first-page":"5861","DOI":"10.1002\/mp.13846","volume":"46","author":"A Rinscheid","year":"2019","unstructured":"Rinscheid A, Kletting P, Eiber M, Beer AJ, Glatting G. Technical note: optimal sampling schedules for kidney dosimetry based on the hybrid planar\/SPECT method in 177Lu-PSMA therapy. Med Phys. 2019;46:5861\u20136.","journal-title":"Med Phys"},{"key":"721_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40658-020-00311-0","volume":"7","author":"A Rinscheid","year":"2020","unstructured":"Rinscheid A, Kletting P, Eiber M, Beer AJ, Glatting G. Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry. Ejnmmi Phys. 2020;7:41.","journal-title":"Ejnmmi Phys"},{"key":"721_CR17","first-page":"37s","volume":"40","author":"JA Siegel","year":"1999","unstructured":"Siegel JA, Thomas SR, Stubbs JB, Stabin MG, Hays MT, Koral KF, et al. MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med. 1999;40:37s.","journal-title":"J Nucl Med."},{"key":"721_CR18","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.2967\/jnumed.111.100123","volume":"53","author":"YK Dewaraja","year":"2012","unstructured":"Dewaraja YK, Frey EC, Sgouros G, Brill AB, Roberson P, Zanzonico PB, et al. MIRD pamphlet No. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy. J Nucl Med. 2012;53:1310\u201325.","journal-title":"J Nucl Med."},{"key":"721_CR19","unstructured":"Joint Committee for Guides in Metrology. Evaluation of measurement data \u2014 Guide to the expression of uncertainty in measurement. S\u00e9vres: Bureau International des Poids et Mesures; 2008."},{"key":"721_CR20","unstructured":"Joint Committee for Guides in Metrology. Evaluation of measurement data \u2013 Supplement 2 to the \u201cGuide to the expression of uncertainty in measurement\u201d\u2014Extension to any number of output quantities. S\u00e9vres: Bureau International des Poids et Mesures; 2011."},{"key":"721_CR21","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1088\/0031-9155\/47\/17\/311","volume":"47","author":"GD Flux","year":"2002","unstructured":"Flux GD, Guy MJ, Beddows R, Pryor M, Flower MA. Estimation and implications of random errors in whole-body dosimetry for targeted radionuclide therapy. Phys Med Biol. 2002;47:3211\u201323.","journal-title":"Phys Med Biol"},{"key":"721_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2967\/jnumed.112.107524","volume":"54","author":"M Sandstr\u00f6m","year":"2013","unstructured":"Sandstr\u00f6m M, Garske-Rom\u00e1n U, Granberg D, Johansson S, Widstr\u00f6m C, Eriksson B, et al. Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment. J Nucl Med. 2013;54:33\u201341.","journal-title":"J Nucl Med"},{"issue":"45","key":"721_CR23","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1007\/s00259-018-4136-7","volume":"I","author":"JI Gear","year":"2018","unstructured":"Gear JI, Cox MG, Gustafsson J, Sj\u00f6green Gleisner K, Murray I, Glatting G, et al. EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations. Eur J Nucl Med Mol. 2018;I(45):2456\u201374.","journal-title":"Eur J Nucl Med Mol"},{"key":"721_CR24","doi-asserted-by":"publisher","first-page":"8329","DOI":"10.1088\/0031-9155\/60\/21\/8329","volume":"60","author":"J Gustafsson","year":"2015","unstructured":"Gustafsson J, Brolin G, Cox M, Ljungberg M, Johansson L, Sj\u00f6green GK. Uncertainty propagation for SPECT\/CT-based renal dosimetry in 177Lu peptide receptor radionuclide therapy. Phys Med Biol. 2015;60:8329\u201346.","journal-title":"Phys Med Biol"},{"key":"721_CR25","unstructured":"B\u00e9 M-M, Chist\u00e9 V, Dulieu C, Browne E, Chechev V, Kuzmenko N, et al. Monographie BIPM-5 Table of radionuclides. s\u00e9vres: bureau international des Poids et Mesures; 2004."},{"key":"721_CR26","unstructured":"Markwardt CB, editor Non-linear least-squares fitting in IDL with MPFIT. Astronomical data analysis software and systems XVII; 2008."},{"key":"721_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13550-022-00947-2","volume":"12","author":"A Stenvall","year":"2022","unstructured":"Stenvall A, Gustafsson J, Larsson E, Roth D, Sundl\u00f6v A, J\u00f6nsson L, et al. Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy. Ejnmmi Res. 2022;12:75.","journal-title":"Ejnmmi Res"},{"issue":"49","key":"721_CR28","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1007\/s00259-022-05786-w","volume":"I","author":"A Sundl\u00f6v","year":"2022","unstructured":"Sundl\u00f6v A, Sj\u00f6green Gleisner K, Tennvall J, Ljungberg M, Warfvinge CF, Holgersson K, et al. Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients. Eur J Nucl Med Mol. 2022;I(49):3830\u201340.","journal-title":"Eur J Nucl Med Mol"},{"key":"721_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2967\/jnumed.121.262069","volume":"63","author":"D Roth","year":"2022","unstructured":"Roth D, Gustafsson J, Warfvinge CF, Sundl\u00f6v A, \u00c5kesson A, Tennvall J, et al. Dosimetric quantities in neuroendocrine tumors over treatment cycles with 177Lu-DOTATATE. J Nucl Med. 2022;63:399\u2013405.","journal-title":"J Nucl Med"},{"key":"721_CR30","first-page":"1058","volume":"37","author":"M Tristam","year":"1996","unstructured":"Tristam M, Alaamer AS, Fleming JS, Lewington VJ, Zivanovic MA. Iodine-131-metaiodobenzylguanidine dosimetry in cancer therapy: risk versus benefit. J Nucl Med. 1996;37:1058\u201363.","journal-title":"J Nucl Med"},{"key":"721_CR31","doi-asserted-by":"publisher","first-page":"923","DOI":"10.2967\/jnumed.123.267023","volume":"65","author":"K Hebert","year":"2024","unstructured":"Hebert K, Santoro L, Monnier M, Castan F, Berkane I, Ass\u00e9nat E, et al. Absorbed dose\u2013response relationship in patients with gastroenteropancreatic neuroendocrine tumors treated with [177Lu]Lu-DOTATATE: one step closer to personalized medicine. J Nucl Med. 2024;65:923\u201330.","journal-title":"J Nucl Med"},{"key":"721_CR32","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.2967\/jnumed.120.254656","volume":"62","author":"XC Hou","year":"2021","unstructured":"Hou XC, Brosch J, Uribe C, Desy A, B\u00f6ning G, Beauregard JM, et al. Feasibility of single-time-point dosimetry for radiopharmaceutical therapies. J Nucl Med. 2021;62:1006\u201311.","journal-title":"J Nucl Med"},{"key":"721_CR33","unstructured":"Joint Committee for Guides in Metrology. Evaluation of measurement data \u2014 Supplement 1 to the \u201cGuide to the expression of uncertainty in measurement\u201d \u2014 Propagation of distributions using a Monte Carlo method. S\u00e9vres: Bureau International des Poids et Mesures; 2008."},{"key":"721_CR34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2307\/2983598","volume":"1","author":"OL Davies","year":"1934","unstructured":"Davies OL, Pearson ES. Methods of estimating from samples the population standard deviation. Suppl J R Stat Soc. 1934;1:76\u201393.","journal-title":"Suppl J R Stat Soc"},{"key":"721_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40658-020-00328-5","volume":"7","author":"D Finocchiaro","year":"2020","unstructured":"Finocchiaro D, Gear JI, Fioroni F, Flux GD, Murray I, Castellani G, et al. Uncertainty analysis of tumour absorbed dose calculations in molecular radiotherapy. Ejnmmi Phys. 2020;7:63.","journal-title":"Ejnmmi Phys"},{"key":"721_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40658-024-00667-7","volume":"11","author":"J Gustafsson","year":"2024","unstructured":"Gustafsson J, Larsson E, Ljungberg M, Sj\u00f6green GK. Pareto optimization of SPECT acquisition and reconstruction settings for 177Lu activity quantification. Ejnmmi Phys. 2024;11:62.","journal-title":"Ejnmmi Phys"},{"key":"721_CR37","doi-asserted-by":"publisher","first-page":"085012","DOI":"10.1088\/1361-6560\/ab7971","volume":"65","author":"J Gustafsson","year":"2020","unstructured":"Gustafsson J, Rode\u00f1o E, M\u00ednguez P. Feasibility and limitations of quantitative SPECT for 223Ra. Phys Med Biol. 2020;65:085012.","journal-title":"Phys Med Biol"},{"key":"721_CR38","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1118\/1.3358119","volume":"37","author":"B He","year":"2010","unstructured":"He B, Frey EC. Effects of shortened acquisition time on accuracy and precision of quantitative estimates of organ activity. Med Phys. 2010;37:1807\u201315.","journal-title":"Med Phys"},{"key":"721_CR39","doi-asserted-by":"publisher","first-page":"976","DOI":"10.2967\/jnumed.115.155390","volume":"56","author":"K Sj\u00f6green Gleisner","year":"2015","unstructured":"Sj\u00f6green Gleisner K, Brolin G, Sundl\u00f6v A, Mjekiqi E, \u00d6stlund K, Tennvall J, et al. Long-term retention of 177Lu\/177mLu-DOTATATE in patients investigated by \u03b3-spectrometry and \u03b3-camera imaging. J Nucl Med. 2015;56:976\u201384.","journal-title":"J Nucl Med"}],"container-title":["EJNMMI Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40658-025-00721-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40658-025-00721-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40658-025-00721-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T03:44:30Z","timestamp":1738813470000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmiphys.springeropen.com\/articles\/10.1186\/s40658-025-00721-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["721"],"URL":"https:\/\/doi.org\/10.1186\/s40658-025-00721-y","relation":{},"ISSN":["2197-7364"],"issn-type":[{"value":"2197-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"assertion":[{"value":"31 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient data were retrieved from the Iluminet trial (EudraCT No 2011\u2013000240\u201316, Regionala etikpr\u00f6vningsn\u00e4mnden Lund, Dnr 2011\/287). Written informed consent for participation in the study was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate:"}},{"value":"All patients participating in the trial consented to their anonymized data being published in scientific journals prior to enrolment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}